Clinical Trial Update: Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial results show efficacy and safety of olokizumab in rheumatoid arthritis patients who previously failed anti-TNF therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Olokizumab (olokizumab)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED